韩国人口中的甘油三和高血压:个体级别的孟德尔随机化分析
1Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon 34054, Republic of Korea.
Nutrients
|February 27, 2026
概括
在观察性研究中,高甘油 (TG) 水平与高血压有很强的关联. 然而,韩国成年人的门德尔随机化分析提供了对因果关系的不确的遗传证据,表明TG可能反映了更广泛的心脏代谢问题.
科学领域:
- 心血管遗传学 心血管遗传学
- 代谢性疾病研究研究
- 流行病学 流行病学
背景情况:
- 在观察性研究中,高水平的甘油三 (TG) 经常与高血压有关.
- TGs在高血压发展中的因果作用尚不确定,特别是在东亚人群中.
- 关于不同种族群体的TG-高血压关系的证据有限.
研究的目的:
- 调查三糖水平对高血压的潜在因果作用.
- 为了评估这种关系,在韩国成年人群中使用孟德尔的随机化.
- 将遗传证据与对TG和高血压的观察结果进行比较.
主要方法:
- 分析了来自2159名韩国成年人的个体级遗传和表型数据.
- 全基因组关联分析确定了与TG相关的SNP作为工具变量 (IV).
- 采用了两阶段IV孟德尔随机化框架和逻辑回归.
主要成果:
- 观察分析显示,TG水平与高血压之间存在显著的正相关性.
- 确定了三种与TG相关的SNP,但解释了有限的TG变异 (部分R2 0.0080.020).
- 门德尔随机化的估计在方向上是正的,但在统计学上是无意义的,表明精度低.
结论:
- 观察数据强烈关联TG水平与高血压在这个韩国队列.
- 门德尔的随机化为因果关系提供了不确定的遗传证据.
- TG水平可能表明更广泛的心脏代谢失调,而不是高血压的孤立原因.
相关概念视频
Randomized Experiments
9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.1K
Regression Toward the Mean
7.2K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
63
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
Atherosclerosis III: Management
516
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516

